Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary Ann Fallon
Mary Ann Fallon
GlaxoSmithKline
Medicine
Lamivudine
Zidovudine
Sida
Viral disease
4
Papers
773
Citations
0.09
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.
1996
AIDS
Daniel R. Kuritzkes
Joseph B. Quinn
Sharon L. Benoit
David Shugarts
Aaron Griffin
Minoo Bakhtiari
David Poticha
Joseph J. Eron
Mary Ann Fallon
Marc Rubin
Show All
Source
Cite
Save
Citations (162)
Lamivudine Plus Zidovudine Compared with Zalcitabine Plus Zidovudine in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Trial
1996
Annals of Internal Medicine
John Bartlett
Sharon L. Benoit
Victoria A. Johnson
Joseph B. Quinn
Gladys E. Sepulveda
W. Christopher Ehmann
Chris Tsoukas
Mary Ann Fallon
Pamela Self
Marc Rubin
Show All
Source
Cite
Save
Citations (102)
Lamivudine Plus Zidovudine Compared with Zalcitabine Plus Zidovudine in Patients with HIV Infection
1996
Annals of Internal Medicine
John Bartlett
Sharon L. Benoit
Victoria A. Johnson
Joseph B. Quinn
Gladys E. Sepulveda
W. Christopher Ehmann
Chris Tsoukas
Mary Ann Fallon
Pamela L. Self
Marc Rubin
Show All
Source
Cite
Save
Citations (32)
Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter
1995
The New England Journal of Medicine
Joseph J. Eron
Sharon L. Benoit
Joseph Jemsek
Rodger David MacArthur
Jorge Santana
Joseph B. Quinn
Daniel R. Kuritzkes
Mary Ann Fallon
Marc Rubin
Show All
Source
Cite
Save
Citations (477)
1